Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Published Online: 2019-12-?
Journal: Annals of OncologyLoading...
Authors: A. Ali•A. Birtle•A. Cook•A. Hoyle•A. Lydon•A. MacNair•A. Nikapota•A. Omlin•A. Protheroe•A. Zarkar•A.W.S. Ritchie•C.C. Parker•C.D. Brawley•C.L. Amos•D. Gilbert•D. Matheson•D.P. Dearnaley•F.C. Ingleby•G. Attard•H. Douis•H. Rush•J. Brown•J. Calvert•J. Gale•J. Wagstaff•J. Wallace•J. Wylie•J.M. O'Sullivan•J.M. Russell•J.S. Tanguay•L. Capaldi•M. Simms•M.D. Mason•M.K.B. Parmar•M.R. Sydes•N.D. James•N.N. Srihari•N.W. Clarke•O. Parikh•R. Millman•R.E. Langley•R.J. Jones•S. Beesley•S. Chowdhury•S. Gibbs•S. Gillessen•S. Rudman•S. Tolan•W. Cross•Z. Malik
